Use of AI can be a controversial subject, but in many ways, it's improving patient's experiences and helping doctors detect ...

As of Friday, February 27, Fulgent Genetics, Inc.’s FLGT share price has dipped by 31.34%, which has investors questioning if this is right time to buy.

A new report shows that agricultural corporations and big tech is pricing innovation out of reach of smallholder farmers who need it most.

The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing intervalCommercial ...

The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.

Neuron-powered computer chips can now be easily programmed to play a first-person shooter game, bringing biological computers a step closer to useful applications ...